USA flag logo/image

An Official Website of the United States Government

Company Information:

Name: Q THERAPEUTICS, INC.
Address: Q THERAPEUTICS, INC.
421 WAKARA WAY, STE 201
SALT LAKE CITY, UT 84108
Located in HUBZone: No
Woman-Owned: No
Minority-Owned: No
URL: N/A
Phone: (801) 581-0400

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $294,914.00 3

Award List:

NUCLEAR/CYTOPLASMIC RATIO-EFFECTS ON EMBRYO DEVELOPMENT

Award Year / Program / Phase: 1992 / SBIR / Phase I
Agency: HHS
Principal Investigator: Frank l. barnes , PRINCIPAL INVESTIGATOR
Award Amount: $49,996.00

A novel technology for protein delivery to the CNS

Award Year / Program / Phase: 2004 / SBIR / Phase I
Agency: HHS
Principal Investigator: Mani Ramaswami
Award Amount: $126,563.00
Abstract:
DESCRIPTION (provided by applicant): The long-term objective of this research is to develop a cell-based system for delivering therapeutic gene products to brain and spinal cord. Several candidate protein pharmaceuticals exist whose use for treatment of genetic or other CNS disorders is severely… More

Development of Astrocyte-Restricted Precursors for Cell Therapy and Drug Screenin

Award Year / Program / Phase: 2010 / SBIR / Phase I
Agency: HHS
Principal Investigator: Robert W. Sandrock
Award Amount: $118,355.00
Abstract:
DESCRIPTION (provided by applicant): The long-term objective of this research is to develop a cell therapy for the treatment of neurological disorders that are due to dysfunctional astrocytes. Current approaches to cure or manage these diseases by small mo lecule drugs are limited due to the… More